World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: SLCTR
Last refreshed on: 27 April 2013
Main ID:  SLCTR/2008/015
Date of registration: 18/07/2008
Primary sponsor: National Science Foundation
Public title: The efficacy of letrozole compared to clomifene in induction and augmentation of ovulation in infertility
Scientific title: A study on anti-eostrogen clomifene citrate and aromatase inhibitor letrozole in induction of ovulation, in WHO group II anovulatory subjects, and in augmentation of ovulation in ovulatory infertility
Date of first enrolment: 15/8/2008
Target sample size: Phase 1: 100, Phase 2 : 25 in each arm
Recruitment status: Completed
URL:  http://www.slctr.lk/trial_details.asp?reg_id={0731F326-F0AC-4B04-89C1-9D8792AB9DE5}
Study type:  Interventional
Study design:  Phase one would be an interventional study Phase two of the study would be a randomised clinical trial  
Countries of recruitment
Sri Lanka
Contacts
Name: Dr. Thilina S Palihawadana 
Address:  Faculty of Medicine, No 6, Thalagolla Road, Ragama
Telephone: 0714 089474
Email: palihawadana_t@sltnet.lk
Affiliation:  Lecturer, Dept of Obs and Gyn
Name: Dr. Thilina S Palihawadana 
Address:  Faculty of Medicine, No 6, Thalagolla Road, Ragama
Telephone: 0714089474
Email: palihawadana_t@sltnet.lk
Affiliation:  Lecturer, Dept of Obs and Gyn
Key inclusion & exclusion criteria
Inclusion criteria: Phase I: participants with WHO group II anovulatory infertility
Phase II: Participants with unexplained infertility

Exclusion criteria: 1. Previous ovarian surgery
2. Endocrinopathies (other than PCOS) giving rise to anovulation


Age minimum:
Age maximum:
Gender:
Health Condition(s) or Problem(s) studied
Anovulatory and unexplained infertility
Intervention(s)
In phase one: ovulation induction with clomifene citrate followed by letrozole in patients with anovulatory infertility In phase two: Subjects with unexplained infertility would undergo augmentation of ovulation with either clomifene citrate or letrozole randomly followed by other agent after a three month drug free interval
Primary Outcome(s)
Phase 1: Ovulation rate, endometrial characteristics
Phase 2: Monofolicle development rate, endometrial characteristics
Secondary Outcome(s)
Follicular phase and luteal phase endocrinological changes
Secondary ID(s)
None
Source(s) of Monetary Support
Self funded
Secondary Sponsor(s)
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history